Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
For more than 15 years, our scientists have provided a unique combination of insight and innovation building quantitative models of the interactions between the human body, drug effects, and diseases. By using these models, Certara is able to help our clients identify the most informative clinical trial designs. These integrated models are being used to design, test and explore various untested clinical scenarios through computer-based simulation. Our core offerings and expertise support dose selection, trial design, labeling and strategic program decisions (e.g., go/no-go).
The benefits of quantitative drug-disease-trial modeling and simulation have been well-demonstrated by FDA and industry sponsors. Contact us today to see how we can help you achieve tangible benefits for your development programs, such as:
Certara consultants help our clients achieve success by supporting regulatory communications and providing trial simulation and design support from pre-clinical studies to post-marketing.